This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
This medicine was previously available in 40mg and 80mg strength, for which patients had to consume 2 tablets a day as per the approved dosage
He will continue to lead business in LATAM and Asia regions in this new role
he financing was significantly oversubscribed with high demand from both existing and new investors.
Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
Dr. Raman has succeeded Victoria Richon
Evonik invests in start-up to improve patient recovery after open-chest surgery
Waksal holds a successful track record of founding, scaling and advising growth-oriented companies.
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Subscribe To Our Newsletter & Stay Updated
